Artivion (AORT) Stock Is Up, What You Need To Know [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
The firm's positive outlook was based on the accelerating growth of Artivion's On-X mechanical valve business. This view was supported by two newly published clinical studies showing the benefits of mechanical valves over other alternatives for patients 65 years and younger. Artivion's management believed these studies created an additional $100 million market opportunity in the U.S. Adding to the positive sentiment, other analysts also showed increased confidence; Oppenheimer raised its price target to $50, and Needham increased its price target to $58, with both firms keeping their positive ratings on the stock. After the initial pop the shares cooled down to $47.01, up 2.4% from previous close. Is now the time to buy Artivion? Access our full analysis report here Artivion's shares are not very volatile and have only had 6 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be som
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- 3 Cash-Producing Stocks with Questionable Fundamentals [Yahoo! Finance]Yahoo! Finance
- Artivion (NYSE:AORT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..MarketBeat
- Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest [Yahoo! Finance]Yahoo! Finance
- Strong Q3 Results and Raised Outlook Could Be a Game Changer for Artivion (AORT) [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 11/6/25 - Beat
AORT
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 144
- 12/9/25 - Form 4
- AORT's page on the SEC website